Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
GSK PLC Sponsored ADR (GSK) had Free Cash Flow of $1.28B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$10.28B |
|
$2.34B |
|
$2.53B |
|
$7.75B |
|
$7.19B |
|
$3.09B |
|
$-200.78M |
|
$2.89B |
|
$2.89B |
|
$2.48B |
|
$2.48B |
|
$2.48B |
|
$2.48B |
|
$3.09B |
|
$3.71B |
|
2.01B |
|
2.04B |
|
$1.16 |
|
$1.15 |
|
| Balance Sheet Financials | |
$23.93B |
|
$12.59B |
|
$60.78B |
|
$84.72B |
|
$30.22B |
|
$18.88B |
|
$31.02B |
|
$61.24B |
|
$23.48B |
|
$-10.78B |
|
$23.48B |
|
2.01B |
|
| Cash Flow Statement Financials | |
$1.54B |
|
$-1.98B |
|
$366.52M |
|
$4.38B |
|
$4.31B |
|
$-68.72M |
|
-- |
|
$-866.44M |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.79 |
|
-- |
|
-- |
|
0.45 |
|
1.09 |
|
75.42% |
|
30.06% |
|
30.06% |
|
-- |
|
28.10% |
|
22.77% |
|
|
Free Cash Flow |
$1.28B |
-- |
|
-- |
|
-- |
|
0.12 |
|
0.30 |
|
0.96 |
|
93.63 |
|
10.56% |
|
-22.98% |
|
2.93% |
|
5.85% |
|
$11.68 |
|
$0.63 |
|
$0.75 |
|